City National Bank’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$14.4M Buy
482,521
+45,261
+10% +$1.45M 0.12% 166
2015
Q2
$13.9M Buy
437,260
+12,914
+3% +$421K 0.11% 177
2015
Q1
$14M Buy
424,346
+8,957
+2% +$285K 0.12% 177
2014
Q4
$12.3M Buy
415,389
+6,132
+1% +$176K 0.11% 194
2014
Q3
$11.5M Buy
409,257
+54,447
+15% +$1.53M 0.11% 204
2014
Q2
$9.99M Buy
354,810
+75,345
+27% +$2.15M 0.09% 211
2014
Q1
$8.52M Sell
279,465
-2,269
-0.8% -$67.7K 0.12% 182
2013
Q4
$8.19M Buy
281,734
+10,481
+4% +$305K 0.12% 186
2013
Q3
$7.39M Buy
271,253
+26,259
+11% +$714K 0.13% 181
2013
Q2
$6.51M Buy
+244,994
New +$6.77M 0.12% 198

Other funds holding PFE

City National Bank's PFE Position: Q3 2015 in Review

City National Bank increased its Pfizer (PFE) stake by 10% in Q3 2015, buying an estimated $1.45M and bringing the position to 482,521 shares worth $14.4M. The position accounts for 0.12% of the portfolio, ranked #166.

City National Bank first reported a position in PFE in Q2 2013 and has held it in 10 quarters since. 1,879 funds tracked by Wall St. Rank hold PFE as of Q3 2015.

  • City National Bank held 482,521 shares of Pfizer worth $14.4M as of Q3 2015.
  • City National Bank bought 45,261 Pfizer shares in Q3 2015, an estimated $1.45M.
  • Pfizer made up 0.12% of City National Bank's portfolio in Q3 2015, its #166 holding.
  • City National Bank first reported a position in Pfizer in Q2 2013 and has held it in 10 quarters since.
  • 1,879 funds tracked by Wall St. Rank held Pfizer as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.